Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer
Lysine-specific demethylase 6A (KDM6A) and members of the Switch/Sucrose Non-Fermentable (SWI/SNF) family are known to counteract the activity of Enhancer of Zeste Homolog 2 (EZH2), which is often overexpressed and is associated with poor prognosis in muscle-invasive bladder cancer. Here we provide...
| Autores principales: | Ramakrishnan, S., Granger, V., Rak, M., Hu, Q., Attwood, K., Aquila, L., Krishnan, N., Osiecki, R., Azabdaftari, G., Guru, K., Chatta, G., Gueron, G., McNally, L., Ohm, J., Wang, J., Woloszynska, A. |
|---|---|
| Formato: | JOUR |
| Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_13509047_v_n_p_Ramakrishnan |
| Aporte de: |
Ejemplares similares
-
Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer
Publicado: (2019) -
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
por: Ramakrishnan, S., et al. -
Tumors of the urinary bladder /
por: Friedman, Nathan B.
Publicado: (1959) -
Bladder cancer : diagnosis and clinical management /
Publicado: (2015) -
EZH2 as a regulator of cell proliferation in pituitary tumors
por: Zlocowski , N, et al.
Publicado: (2021)